Stand Up To Cancer names UNC Lineberger researchers to ‘Dream Team’

January 30, 2019

The multi-institutional team, which is co-led by UNC Lineberger’s Gianpietro Dotti, MD, and includes six UNC Lineberger researchers, will focus on developing chimeric antigen receptor T-cell (CAR-T) therapies to recognize and attack T-cell lymphoma, a group of rare cancers of the blood and immune system.